Phathom Pharmaceuticals, Inc. Beginning Cash

Beginning Cash of PHAT for past 10 years: annual, quarterly and twelve month trailing (TTM) including Beginning Cash growth rates and interactive chart.


Highlights and Quick Summary

  • Beginning Cash for the quarter ending June 30, 2022 was $0 (a -100.0% decrease compared to previous quarter)
  • Year-over-year quarterly Beginning Cash decreased by NaN%
  • Annual Beginning Cash for 2021 was $287 Million (a 17.94% increase from previous year)
  • Annual Beginning Cash for 2020 was $244 Million (a 27632.08% increase from previous year)
  • Twelve month Beginning Cash ending June 30, 2022 was $183 Million (a 0.0% decrease compared to previous quarter)
  • Twelve month trailing Beginning Cash decreased by -36.26% year-over-year
Trailing Beginning Cash for the last four month:
30 Jun '22 31 Mar '22 31 Dec '21 30 Sep '21
$183 Million $183 Million $287 Million $287 Million
Visit stockrow.com/PHAT for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Beginning Cash of Phathom Pharmaceuticals, Inc.

Most recent Beginning Cashof PHAT including historical data for past 10 years.

Interactive Chart of Beginning Cash of Phathom Pharmaceuticals, Inc.

Phathom Pharmaceuticals, Inc. Beginning Cash for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $0.0 $183.26
2021 $0.0 $0.0 $0.0 $287.5 $287.5
2020 $0.0 $0.0 $0.0 $243.77 $243.77
2019 $0.0 $0.0 $0.0 $0.88 $0.88
2018 $0.0

Business Profile of Phathom Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology